Record Information |
---|
Version | 2.0 |
---|
Created at | 2006-05-22 15:12:43 UTC |
---|
Updated at | 2024-09-17 15:44:03 UTC |
---|
NP-MRD ID | NP0001123 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Palmitoleic acid |
---|
Description | Palmitoleic acid, or (9Z)-hexadec-9-enoic acid, is an omega-7 monounsaturated fatty acid (16:1N-7) with the formula CH3(CH2)5CH=CH(CH2)7COOH that is a common constituent of the glycerides of human adipose tissue. Present in all tissues, it is generally found in higher concentrations in the liver. Macadamia oil (Macadamia integrifolia) and sea buckthorn oil (Hippophae rhamnoides) are botanical sources of palmitoleic acid, containing 22 and 40% respectively. Palmitoleic acid is found to be associated with isovaleric acidemia, which is an inborn error of metabolism. |
---|
Structure | InChI=1S/C16H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h7-8H,2-6,9-15H2,1H3,(H,17,18)/b8-7- |
---|
Synonyms | Value | Source |
---|
(9Z)-Hexadecenoic acid | ChEBI | (Z)-9-Hexadecenoic acid | ChEBI | (Z)-Hexadec-9-enoic acid | ChEBI | 16:1DElta9 | ChEBI | 9-cis-Hexadecenoic acid | ChEBI | cis-9-Hexadecenoic acid | ChEBI | cis-9-Palmitoleic acid | ChEBI | cis-delta-9-Hexadecenoic acid | ChEBI | cis-Delta(9)-Hexadecenoic acid | ChEBI | cis-Palmitoleic acid | ChEBI | Oleopalmitic acid | ChEBI | Palmitolinoleic acid | ChEBI | Zoomaric acid | ChEBI | Zoomeric acid | ChEBI | (9Z)-Hexadec-9-enoate | Kegg | (9Z)-Hexadecenoate | Generator | (Z)-9-Hexadecenoate | Generator | (Z)-Hexadec-9-enoate | Generator | 9-cis-Hexadecenoate | Generator | cis-9-Hexadecenoate | Generator | cis-9-Palmitoleate | Generator | cis-delta-9-Hexadecenoate | Generator | cis-Δ-9-hexadecenoate | Generator | cis-Δ-9-hexadecenoic acid | Generator | cis-delta(9)-Hexadecenoate | Generator | cis-Δ(9)-hexadecenoate | Generator | cis-Δ(9)-hexadecenoic acid | Generator | cis-Palmitoleate | Generator | Oleopalmitate | Generator | Palmitolinoleate | Generator | Zoomarate | Generator | Zoomerate | Generator | (9Z)-Hexadec-9-enoic acid | Generator | Palmitoleate | Generator | 9-Hexadecenoate | HMDB | 9-Hexadecenoic acid | HMDB | Hexadecenoate | HMDB | Hexadecenoate (N-C16:1) | HMDB | Hexadecenoic acid | HMDB | Palmitoleic acid, (Z)-isomer | HMDB | Palmitoleic acid, (e)-isomer | HMDB | C16:1 trans-9 | HMDB | Palmitelaidic acid | HMDB | (9Z)-9-Hexadecenoic acid | HMDB | 9Z-Hexadecenoic acid | HMDB | C16:1 | HMDB | FA(16:1(9Z)) | HMDB | FA(16:1n7) | HMDB | cis-delta9-Hexadecenoic acid | HMDB | cis-Δ9-hexadecenoic acid | HMDB | Palmitoleic acid | HMDB |
|
---|
Chemical Formula | C16H30O2 |
---|
Average Mass | 254.4082 Da |
---|
Monoisotopic Mass | 254.22458 Da |
---|
IUPAC Name | (9Z)-hexadec-9-enoic acid |
---|
Traditional Name | palmitoleic acid |
---|
CAS Registry Number | 373-49-9 |
---|
SMILES | CCCCCC\C=C/CCCCCCCC(O)=O |
---|
InChI Identifier | InChI=1S/C16H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h7-8H,2-6,9-15H2,1H3,(H,17,18)/b8-7- |
---|
InChI Key | SECPZKHBENQXJG-FPLPWBNLSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
| Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Species Where Detected | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Fatty Acyls |
---|
Sub Class | Fatty acids and conjugates |
---|
Direct Parent | Long-chain fatty acids |
---|
Alternative Parents | |
---|
Substituents | - Long-chain fatty acid
- Unsaturated fatty acid
- Straight chain fatty acid
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Liquid |
---|
Experimental Properties | |
---|
Predicted Properties | |
---|
General References | - Katsuta Y, Iida T, Inomata S, Denda M: Unsaturated fatty acids induce calcium influx into keratinocytes and cause abnormal differentiation of epidermis. J Invest Dermatol. 2005 May;124(5):1008-13. [PubMed:15854043 ]
- Rossner S, Walldius G, Bjorvell H: Fatty acid composition in serum lipids and adipose tissue in severe obesity before and after six weeks of weight loss. Int J Obes. 1989;13(5):603-12. [PubMed:2583914 ]
- Ho RC, Davy KP, Hickey MS, Summers SA, Melby CL: Behavioral, metabolic, and molecular correlates of lower insulin sensitivity in Mexican-Americans. Am J Physiol Endocrinol Metab. 2002 Oct;283(4):E799-808. [PubMed:12217898 ]
- Yli-Jama P, Haugen TS, Rebnord HM, Ringstad J, Pedersen JI: Selective mobilisation of fatty acids from human adipose tissue. Eur J Intern Med. 2001 Apr;12(2):107-115. [PubMed:11297913 ]
- Prandota J: Clinical pharmacology of antibiotics and other drugs in cystic fibrosis. Drugs. 1988 May;35(5):542-78. [PubMed:3293970 ]
|
---|